Trademark: 79331222
Word

Status
Registered
Status Code
700
Status Date
Tuesday, August 2, 2022
Serial Number
79331222
Registration Number
6805711
Registration Date
Tuesday, August 2, 2022
Mark Type
2000
Filing Date
Monday, June 28, 2021
Published for Opposition
Tuesday, May 17, 2022

Trademark Owner History
Hinye Pharmaceutical Co.,Ltd. - Original Registrant

Classifications
5 Herbal supplements; medicinal herbal preparations; medicinal herbs; herbs for medicinal purposes; Chinese traditional medicinal herbs; medicinal herbal extracts for medical purposes; medicines for the treatment of gastrointestinal diseases; antiallergic medicines; medicines for alleviating constipation; pharmaceutical preparations for the treatment of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; pharmaceutical preparations for the prevention of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammatory disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; chemical preparations for pharmaceutical or medical purposes, namely, for cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; unit dose capsules sold empty for pharmaceutical use; biological preparations for the treatment of cardiovascular disorders, cardiopulmonary disorders, neurological disorders, immune system disorders, metabolic disorders, respiratory disorders, musculoskeletal disorders, genitourinary disorders, inflammatory disorders, dermatological disorders, oncological disorders, hematology disorders, ophthalmic diseases, allergies, pain, inflammation disorders, sepsis, alopecia, obesity and cognitive disorders, sexual dysfunction, hormonal disorders, psychiatric disorders, hepatological disorders, cancer, wounds, endocrine diseases; allergy tablets; antibiotic tablets
The design element above the Chinese characters is comprised of a diamond embedded with a notch and a long curved line. Beneath the design element appears four Chinese characters in horizontal arrangement.
The transliteration of the non-Latin characters in the mark is Tian Di Heng YI
The four Chinese characters Tian Di Heng YI are translated as HINYE. The Chinese characters in the mark and the wording HINYE have no meaning in English.

Trademark Events
Oct 2, 2022
Notification Processed By Ib
Sep 15, 2022
Final Disposition Notice Sent To Ib
Sep 15, 2022
Final Disposition Processed
Sep 1, 2022
Grant Of Protection Created, To Be Sent To Ib
Aug 2, 2022
Registered-Principal Register
May 17, 2022
Published For Opposition
May 16, 2022
Notification Processed By Ib
Apr 27, 2022
Notification Of Possible Opposition Sent To Ib
Apr 27, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 27, 2022
Notice Of Publication
Apr 10, 2022
Approved For Pub - Principal Register
Mar 18, 2022
Assigned To Examiner
Jan 29, 2022
Application Filing Receipt Mailed
Jan 25, 2022
New Application Office Supplied Data Entered In Tram
Jan 24, 2022
Limitation From Original Application Entered
Jan 13, 2022
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24